Mystakidou, MD, PhD K, Katsouda, MD E, Parpa, BA, MA E, Tsiatas, MD, PhD ML, Vlahos, MD, PhD L. Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: An overview of its pharmacological and clinical characteristics. J of Opioid Management [Internet]. 2005 Mar. 1 [cited 2024 Nov. 22];1(1):36-40. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/1046